Ruocai Xu

1.4k total citations · 1 hit paper
11 papers, 349 citations indexed

About

Ruocai Xu is a scholar working on Hepatology, Oncology and Cancer Research. According to data from OpenAlex, Ruocai Xu has authored 11 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 5 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Ruocai Xu's work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Ruocai Xu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Ruocai Xu collaborates with scholars based in China, United States and South Korea. Ruocai Xu's co-authors include Zhenggang Ren, Baek‐Yeol Ryoo, Shukui Qin, Abby B. Siegel, Juxiang Xiao, Gwo Fuang Ho, Xiaohong Chen, Yuxian Bai, Jieer Ying and Jianfeng Li and has published in prestigious journals such as Journal of Clinical Oncology, The American Journal of Gastroenterology and Frontiers in Oncology.

In The Last Decade

Ruocai Xu

11 papers receiving 346 citations

Hit Papers

Pembrolizumab Versus Placebo as Second-Line Therapy in Pa... 2022 2026 2023 2024 2022 40 80 120

Peers

Ruocai Xu
Comparison fields: 5 of 32
  • Hepatology 242
  • Oncology 131
  • Epidemiology 96
  • Cancer Research 71
  • Pathology and Forensic Medicine 68
Replace Thomas Yau with:
Thomas Yau Hong Kong
Christine Dela Cruz United States
Zili Hu China
Claudia Angela Maria Fulgenzi United Kingdom
Yichuan Yuan China
Songqiang Zhou China
Annette Baumhauer Spain
Xuqi Sun China
Wen‐Ping Lin China
Thomas Yau Hong Kong View profile →
Citations per field, relative to Ruocai Xu
Ruocai Xu · 1×
Citations per year, relative to Ruocai Xu
Ruocai Xu · 1×

Countries citing papers authored by Ruocai Xu

Since Specialization
Citations

This map shows the geographic impact of Ruocai Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruocai Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruocai Xu more than expected).

Fields of papers citing papers by Ruocai Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruocai Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruocai Xu. The network helps show where Ruocai Xu may publish in the future.

Co-authorship network of co-authors of Ruocai Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ruocai Xu. A scholar is included among the top collaborators of Ruocai Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruocai Xu. Ruocai Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
# Work Indexed citations
1 1
2 6
3 1
4
Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial breakdown →
127
5 79
6 31
7 6
8 16
9 16
10 7
11 59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026